Intimation of Press release regarding receipt of Significant Order for supply of dry-type shunt Reactors for hyperscale data centre project in Finland.

Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company will hold an Analyst / Investors'' Conference Call on its Unaudited Financial Results for the quarter ended June 30, 2025, on Tuesday, July 29, 2025 at 10:00 a.m. (IST).

Standalone & Consolidated Un-Audited Financial Results for the Quarter Ended 30.06.2025

Indian Toners & Developers Limited has submitted to BSE Limited letter reg. Book Closure Notice for 35th AGM of the Company scheduled on 25.08.2025. (Letter attached)

Publish in Newspaper unaudited financial results for the quarter ended 30.06.2025 as per Regulation 47 of SEBI (LODR).

Pursuant to Reg 47 of the SEBI (LODR) Regulations, please find attached the newspaper publication of the notice of the AGM to be held on Monday, 11th August 2025 at Financial Express (English) and Arthik Lipi (Bengali).

Solara Active Pharma Sciences Limited has informed the Exchange about Schedule of Investors/Analyst call to be held on Friday, 25th July 2025 at 4.00P.M. to discuss the Company''s financial results for the quarter ended June 30, 2025.

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018

In terms of our earlier letter dated 15th July, 2025 we are furnishing herewith a copy of the resignation letter as received from Mr Vijay Mittal, Non-Executive and Non-Independent Director of the company.

Notice of Shareholders Meeting held through postal ballot